Kessler TM - Search Results

1

What a patient with refractory idiopathic detrusor overactivity should know about botulinum neurotoxin type a injection.

Khan S, Kessler TM, Apostolidis A, Kalsi V, Panicker J, Roosen A, Gonzales G, Haslam C, Elneil S, Fowler CJ, Dasgupta P. Khan S, et al. Among authors: kessler tm. J Urol. 2009 Apr;181(4):1773-8. doi: 10.1016/j.juro.2008.11.110. Epub 2009 Feb 23. J Urol. 2009. PMID: 19233414

2

Sacral neuromodulation for urinary retention.

Kessler TM, Fowler CJ. Kessler TM, et al. Nat Clin Pract Urol. 2008 Dec;5(12):657-66. doi: 10.1038/ncpuro1251. Epub 2008 Nov 11. Nat Clin Pract Urol. 2008. PMID: 19002127 Review.

3

Suburothelial myofibroblasts in the human overactive bladder and the effect of botulinum neurotoxin type A treatment.

Roosen A, Datta SN, Chowdhury RA, Patel PM, Kalsi V, Elneil S, Dasgupta P, Kessler TM, Khan S, Panicker J, Fry CH, Brandner S, Fowler CJ, Apostolidis A. Roosen A, et al. Among authors: kessler tm. Eur Urol. 2009 Jun;55(6):1440-8. doi: 10.1016/j.eururo.2008.11.009. Epub 2008 Nov 18. Eur Urol. 2009. PMID: 19054608 Clinical Trial.

4

Re: Lower urinary tract symptoms in dementia with Lewy bodies, Parkinson disease, and Alzheimer disease.

Kessler TM. Kessler TM. Eur Urol. 2008 Aug;54(2):462-3. doi: 10.1016/j.eururo.2008.04.087. Eur Urol. 2008. PMID: 19209433 No abstract available.

5

Sexual dysfunction in multiple sclerosis.

Kessler TM, Fowler CJ, Panicker JN. Kessler TM, et al. Expert Rev Neurother. 2009 Mar;9(3):341-50. doi: 10.1586/14737175.9.3.341. Expert Rev Neurother. 2009. PMID: 19271943 Review.

6

Benign prostatic obstruction and parkinson's disease--should transurethral resection of the prostate be avoided?

Roth B, Studer UE, Fowler CJ, Kessler TM. Roth B, et al. Among authors: kessler tm. J Urol. 2009 May;181(5):2209-13. doi: 10.1016/j.juro.2009.01.049. Epub 2009 Mar 17. J Urol. 2009. PMID: 19296974

7

Clean intermittent self-catheterization after botulinum neurotoxin type A injections: short-term effect on quality of life.

Kessler TM, Khan S, Panicker J, Roosen A, Elneil S, Fowler CJ. Kessler TM, et al. Obstet Gynecol. 2009 May;113(5):1046-1051. doi: 10.1097/AOG.0b013e3181a1f5ea. Obstet Gynecol. 2009. PMID: 19384119 Clinical Trial.

8

Complete continence after botulinum neurotoxin type A injections for refractory idiopathic detrusor overactivity incontinence: patient-reported outcome at 4 weeks.

Khan S, Panicker J, Roosen A, Gonzales G, Elneil S, Dasgupta P, Fowler CJ, Kessler TM. Khan S, et al. Among authors: kessler tm. Eur Urol. 2010 May;57(5):891-6. doi: 10.1016/j.eururo.2009.04.020. Epub 2009 Apr 21. Eur Urol. 2010. PMID: 19394133

9

Cadherin-11 up-regulation in overactive bladder suburothelial myofibroblasts.

Roosen A, Apostolidis A, Elneil S, Khan S, Panicker J, Brandner S, Fowler CJ, Kessler TM. Roosen A, et al. Among authors: kessler tm. J Urol. 2009 Jul;182(1):190-5. doi: 10.1016/j.juro.2009.02.148. Epub 2009 May 17. J Urol. 2009. PMID: 19450843

10

In the human urothelium and suburothelium, intradetrusor botulinum neurotoxin type A does not induce apoptosis: preliminary results.

Kessler TM, Khan S, Panicker JN, Elneil S, Brandner S, Fowler CJ, Roosen A. Kessler TM, et al. Eur Urol. 2010 May;57(5):879-83. doi: 10.1016/j.eururo.2009.09.023. Epub 2009 Sep 11. Eur Urol. 2010. PMID: 19765885

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

248 results

Search Page